BackChemed Overview

Chemed Other Current Assets

Chemed's other current assets is $35M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$34.52M

Peer average

Loading

Chemed Other Current Assets History

Loading

Chemed vs. peers: Other Current Assets Comparison

Loading

Chemed Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Chemed (CHE) FAQ

As of the most recent data (March 2026), CHE shows a other current assets of $35M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CHE's other current assets is now $35M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Chemed is outperforming or lagging.

Tracking CHE's other current assets over time shows whether Chemed is scaling, shrinking, or reshaping that part of the business. The current reading is $35M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Chemed's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $35M) with ownership activity and broader fundamentals.

Chemed's other current assets is $35M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.